These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 7138821)

  • 1. Proton and fluorine nuclear magnetic resonance spectroscopic observation of hemiacetal formation between N-acyl-p-fluorophenylalaninals and alpha-chymotrypsin.
    Gorenstein DG; Shah DO
    Biochemistry; 1982 Sep; 21(19):4679-86. PubMed ID: 7138821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for hemiacetal formation between N-acyl-L-phenylalaninals and alpha-chymotrypsin by cross-saturation nuclear magnetic resonance spectroscopy.
    Chen R; Gorenstein DG; Kennedy WP; Lowe G; Nurse D; Schultz RM
    Biochemistry; 1979 Mar; 18(5):921-6. PubMed ID: 420824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A proton-magnetic-resonance study of N-trifluoroacetyl-L-alanyl-L-phenylalaninal binding to alpha-chymotrypsin.
    Wyeth P; Sharma RP; Akhtar M
    Eur J Biochem; 1980 Apr; 105(3):581-5. PubMed ID: 6245886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of low-barrier hydrogen bonding and oxyanion binding in transition state analogue complexes of chymotrypsin.
    Neidhart D; Wei Y; Cassidy C; Lin J; Cleland WW; Frey PA
    Biochemistry; 2001 Feb; 40(8):2439-47. PubMed ID: 11327865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of the structure of tetrahedral transition state analogues bound at the active site of chymotrypsin using 18O and 2H isotope shifts in the 13C NMR spectra of glyoxal inhibitors.
    Spink E; Hewage C; Malthouse JP
    Biochemistry; 2007 Nov; 46(44):12868-74. PubMed ID: 17927215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Motion at the active site of [(4-fluorophenyl)sulfonyl]chymotrypsin.
    Ando ME; Gerig JT; Luk KF
    Biochemistry; 1986 Aug; 25(17):4772-8. PubMed ID: 3768312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and characterization of a selenium-containing substrate of alpha-chymotrypsin. Selenium-77 nuclear magnetic resonance observation of an acyl-alpha-chymotrypsin intermediate.
    Mullen GP; Dunlap RB; Odom JD
    Biochemistry; 1986 Sep; 25(19):5625-32. PubMed ID: 3778877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-[2,2-dimethyl-3-(N-(4-cyanobenzoyl)amino)nonanoyl]-L-phenylalanine ethyl ester as a stable ester-type inhibitor of chymotrypsin-like serine proteases: structural requirements for potent inhibition of alpha-chymotrypsin.
    Iijima K; Katada J; Yasuda E; Uno I; Hayashi Y
    J Med Chem; 1999 Jan; 42(2):312-23. PubMed ID: 9925737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemiacetal stabilization in a chymotrypsin inhibitor complex and the reactivity of the hydroxyl group of the catalytic serine residue of chymotrypsin.
    Cleary JA; Doherty W; Evans P; Malthouse JP
    Biochim Biophys Acta; 2014 Jun; 1844(6):1119-27. PubMed ID: 24657307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure and dynamics of alpha-chymotrypsin-N-trifluoroacetyl-4-fluorophenylalanine complexes.
    Jacobson AR; Gerig JT
    J Biomol NMR; 1991 Jul; 1(2):131-44. PubMed ID: 1841692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conformational dynamics in fluorophenylcarbamoyl-alpha-chymotrypsins.
    Kairi M; Gerig JT
    Biochim Biophys Acta; 1990 Jun; 1039(2):157-70. PubMed ID: 2364092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorine magnetic resonance studies of fluorine-substituted benzoyl chymotrypsins.
    Amshey JW; Bender ML
    Arch Biochem Biophys; 1983 Jul; 224(1):378-81. PubMed ID: 6870262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specificity and stereospecificity of alpha-chymotrypsin.
    Ingles DW; Knowles JR
    Biochem J; 1967 Aug; 104(2):369-77. PubMed ID: 6048779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An application of transient nuclear magnetic resonance methods to the measurement of biological exchange rates. The interaction of trifluoroacetyl-D-phenylalanine with the chymotrypsins.
    Sykes BD
    J Am Chem Soc; 1969 Feb; 91(4):949-55. PubMed ID: 5778277
    [No Abstract]   [Full Text] [Related]  

  • 15. 13C-NMR study of the inhibition of delta-chymotrypsin by a tripeptide-glyoxal inhibitor.
    Djurdjevic-Pahl A; Hewage C; Malthouse JP
    Biochem J; 2002 Mar; 362(Pt 2):339-47. PubMed ID: 11853541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The deuterium isotope effect on the NMR signal of the low-barrier hydrogen bond in a transition-state analog complex of chymotrypsin.
    Cassidy CS; Lin J; Frey PA
    Biochem Biophys Res Commun; 2000 Jul; 273(2):789-92. PubMed ID: 10873682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzyme-inhibitor interactions studies via fluorine nuclear magnetic resonance. I. The interaction of alpha-chymotrypsin with DL-N-trifluoroacetylphenylalanie.
    Zeffren E; Reavill RE
    Biochem Biophys Res Commun; 1968 Jul; 32(1):73-80. PubMed ID: 5672545
    [No Abstract]   [Full Text] [Related]  

  • 18. Evidence for multiple forms of p-trifluoromethylbenzenesulfonyl-alpha-chymotrypsin.
    Ando ME; Gerig JT; Luk KF; Roe DC
    Can J Biochem; 1980 May; 58(5):427-33. PubMed ID: 7407679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reactions of alpha-chymotrypsin with 4-(trifluoromethyl)-alpha-bromoacetanilide.
    Ando ME; Gerig JT
    Biochemistry; 1982 May; 21(10):2299-304. PubMed ID: 7093189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The second nucleophile molecule binds to the acyl-enzyme-nucleophile complex in alpha-chymotrypsin catalysis. Kinetic evidence for the interaction.
    Gololobov MY; Stepanov VM; Voyushina TL; Adlercreutz P
    Eur J Biochem; 1993 Nov; 217(3):955-63. PubMed ID: 8223653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.